glp-1 ban Who Gets the Shot? Access by State GLP-1 weight loss drugs are

Biol pii: S0012-1606(16)3: 1-11 (2017)

Whilst the evidence base remains limited, emerging data show greater cardiac mass amongst AAS users (Far et al, 2012) and evidence of significantly reduced ejection fraction and higher coronary artery plaque volume among current AAS users, as compared to non-users or those currently off cycle (Baggish et al, 2017)

Clinical studies have shown that the Bacillus coagulans strain is effective in the treatment of irritable bowel syndrome (IBS) and functional abdominal pain in adults, as well as IBS and constipation in children

1 2 "Kava: A Human Health Risk Assessment" (PDF)

Their approach focuses on supporting satiety, minimizing energy crashes, and promoting efficient fat metabolism through proven botanicals

For those that want to remove an angiokeratoma lesion, laser or freezing are the usual options